Coenzyme Q10 could slow Parkinson’s

The nutritional supplement coenzyme Q10 could slow the progress of early-stage Parkinson’s.


Eighty patients with early Parkinson’s disease, recruited from 10 centres across the USA, were randomly assigned to receive wafers containing coenzyme Q10 at a dose of 300, 600 or 1200 mg/day, or placebo. Patients were followed up for 16 months.


The patients taking placebo showed a slight disease progression whereas the groups treated with coenzyme Q10 experienced less progression. This was most striking in the group that received the highest dose – they experienced a 44 per cent reduction in the worsening of their symptoms (Arch Neurol, 2002; 59: 1541-50).

What Doctors Don't Tell You Written by What Doctors Don't Tell You

Get the Healthiest Newsletter!

Get a dose of Healthy delivered straight to your inbox. Each FREE issue features amazing content that will elevate your Body, Mind, and Spirit.

Your data is never shared with 3rd parties

Body+Mind+Spirit

TRANSFORM YOUR LIFE?

Try the Internet's Longest-Running Wellness Program.